CellaVision AB

51
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000683484
SEK
157.20
-3.2 (-2.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
CellaVision AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
176.00
164.00
148.00
158.00
112.00
129.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-15.00
10.00
-28.00
-11.00
-35.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
198.00
196.00
137.00
159.00
71.00
125.00
Cash Flow from Investing Activities
-76.00
-85.00
-70.00
-84.00
-34.00
-266.00
Cash Flow from Financing Activities
-95.00
-97.00
-90.00
-48.00
-35.00
72.00
Net Cash Inflow / Outflow
27.00
13.00
-22.00
28.00
0.00
-66.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CellaVision AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
176.86
261.6
-85.00
-32.39%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-15.412
71.7
-86.00
-121.50%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
198.437
360
-162.00
-44.88%
Cash Flow from Investing Activities
-76.006
-128.7
52.00
40.94%
Cash Flow from Financing Activities
-95.089
-46.1
-49.00
-106.27%
Net Cash Inflow / Outflow
27.785
182
-155.00
-84.73%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.443
-3.2
3.00
113.84%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 1.02% vs 43.09% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
198.44
196.44
1.02%